Publikationen

Die Medizinische Klinik für Nephrologie CBF der Charité – Universitätsmedizin Berlin weist an dieser Stelle auf publizierte Forschungsergebnisse der Klinik hin.

Unten aufgeführt ist eine nach Jahren sortierte Übersicht der einzelnen Veröffentlichungen ab 1994.

Sie befinden sich hier:

Renal and Vascular Research Group

Publikationen 2017

1.   Anderson, J.; Gautier, T.; Nijstad, N.; Tölle, M.; Schuchardt, M.; van der Giet, M.; Tietge, U.: High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport, Sci Rep, 2017.

2.   Reshetnik, A.; Gohlisch, C.; Tölle, M.; Zidek, W.; Van Der Giet, M.: Oscillometric assessment of arterial stiffness in everyday clinical practice, Hypertens Res, 2016.

3.    Holdaas, H.; de Fijter, J.W.; Cruzado, J.M.; Massari, P.; Nashan, B.; Kanellis. J.; Witzke, O.; Gutierrez-Dalmau, A.; Turkmen, A.; Wang, Z.; Lopez, P.; Bernhardt, P.; Kochuparampil, J.; van der Giet, M.; Murbraech, K.; ELEVATE Study Group: Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study, Transplantation, 2017.

4.   Michalick, L.; Erfinanda, L.; Weichelt, U.; van der Giet, M.; Liedtke, W.; Kuebler, W.M.: Transient Receptor Potential Vanilloid 4 and Serum Glucocorticoid-regulated Kinase 1 Are Critical Mediators of Lung Injury in Overventilated Mice In Vivo, Anesthesiology, 2017.

5.   Schuchardt, M.; Herrmann, J.; Tölle, M.; van der Giet, M.: Xanthine oxidase and its role as target in cardiovascular disease: cardiovascular protection by enzyme inhibition?, Curr Pharm Des., 2017.

6.   Alicke, M.; Boakye-Appiah, J.K.; Abdul-Jalil, I.; Henze, A.; van der Giet, M.; Schulze, M.B.; Schweigert, F.J.; Mockenhaupt, F.; Bedu-Addo, G.; Danquah, I.: Adolescent health in rural Ghana: A cross-sectional study on the co-occurrence of infectious diseases, malnutrition and cardio-metabolic risk factors, PLoS One, 2017.

7.   Schaafs, L.A.; Tzschätzsch, H.; van der Giet, M.; Reshetnik, A.; Steffen, I.G.; Hamm, B.; Braun, J.; Sack, I.; Elgeti, T.: Time-Harmonic Ultrasound elastography of the Descending Abdominal Aorta: Initial Results, Ultrasound Med Biol., 2017.

8.   Ebert, N.; Jakob, O.; Gaedeke, J.; van der Giet, M.; Kuhlmann, M.K.; Martus, P.; Mielke, N.; Schuchardt, M.; Tölle, M.; Wenning, V.; Schaeffner, E.S.: Prevalence of reduced kidney function and albuminuria in older adults: the Berlin Initiative Study, Nephrol Dial Transplant., 2017.

9.   Ebert, N.; Koep, C.; Schwarz, K.; Martus, P.; Mielke, N.; Bartel, J.; Kuhlmann, M.; Gaedeke, J.; Toelle, M.; van der Giet, M.; Schuchardt, M.; Schaeffner, E.: Beta Trace Protein does not outperform Creatinine and Cystatin C in estimating Glomerular Filtration Rate in Older Adults, Sci Rep., 2017.

10.  Koziolek, M.; Beige, J.; Wallbach, M.; Zenker, D.; Henning, G.; Halbach, M.; Mader, N.; Mahfoud, F.; Schlieper, G.; Schwenger, V.; Hausberg, M.; Börgel, J.; Lodde, M.; van der Giet, M.; Müller-Ehmsen, J.; Passauer, J.; Parmentier. S.; Lüders, S.; Krämer, B.K.; Büttner, S.; Limbourg, F.; Jordan, J.; Vonend, O.; Predel, H.G.; Reuter, H.: Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017[Article in German], Internist, 2017.

11.    Bedu-Addo, G.; Alicke, M.; Boakye-Appiah, J.K.; Abdul-Jalil, I.; van der Giet, M.; Schulze, M.B.; Mockenhaupt, F.P.; Danquah, I.: In utero exposure to malaria is associated with metabolic traits in adolescence: The Agogo 2000 birth cohort study, J Infect., 2017.

12.   Lobo, M.D.; Ott, C.; Sobotka, P.A.; Saxena, M.; Stanton, A.; Cockcroft, J.R.; Sulke, N.; Dolan, E.; van der Giet, M.; Hoyer, J.; Furniss, S.S.; Foran, J.P.; Witkowski, A.; Januszewicz, A.; Schoors, D.; Tsioufis, K.; Rensing, B.J.; Scott, B.; Ng, G.A.; Schmieder, R.E.: Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial, Hypertension, 2017.

13.   Kakkassery, V.; Skosyrski, S.; Lüth, A.;, Kleuser, B.; van der Giet, M.; Tate, R.; Reinhard, J.; Faissner, A.; Joachim, S.C.; Kociok, N.: Etoposide Upregulates Survival Favoring Sphingosine-1-Phosphate in Etoposide-Resistant Retinoblastoma Cells, Pathol Oncol Res., 2017.

Publikationen 2016

1.    Ebert, N.; Delanaye, P.; Shlipak, M.; Jakob, O.; Martus, P.; Bartel, J, Gaedeke, J.; van der Giet, M.; Schuchardt, M.; Cavalier, E.; Schaeffner, E.: Cystatin C standardization decreases assay variation and improves assessment of glomerular filtration rate, Clin Chim Acta, 2016.

2.    Assfalg, V.; Hüser, N.; van Meel, M.; Haller, B.; Rahmel, A.; de Boer, J.; Matevossian, E.; Novotny, A.; Knops, N.; Weekers, L.; Friess, H.; Pratschke, J.; Függer, R.; Janko, O.; Rasoul-Rockenschaub, S.; Bosmans, J.L.; Broeders, N.; Peeters, P.; Mourad, M.; Kuypers, D.; Slaviček, J.; Muehlfeld, A.; Sommer, F.; Viebahn, R., Pascher, A.; van der Giet, M.; Zantvoort, F., Woitas, R.P.; Putz, J.; Grabitz, K.; Kribben, A.; Hauser, I.; Pisarski, P.; Weimer, R.; Lorf, T.; Fornara, P.; Morath, C., Nashan, B.; Lehner, F.; Kliem, V.; Sester, U.; Grimm, M.O.; Feldkamp, T.; Kleinert, R., Arns, W.; Mönch, C.; Schoenberg, M.B.; Nitschke, M.; Krüger, B.; Thorban, S.; Arbogast, H.P.; Wolters, H.H.; Maier, T.; Lutz, J.; Heller, K.; Banas, B.; Hakenberg, O.; Kalus, M.; Nadalin, S.; Keller, F.; Lopau, K.; Bemelman, F.J.; Nurmohamed, S.; Sanders, J.S.; de Fijter, J.W.; Christiaans, M.; Hilbrands, L.; Betjes, M.; van Zuilen, A.; Heemann, U.: High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System: success or waste of organs? The Eurotransplant 15-year all-centre survey, Nephrol Dial Transplant., 2016.

3.    Ebert, N.; Jakob, O.; Gaedeke, J,; van der Giet, M,; Kuhlmann, M.K.; Martus, P.; Mielke, N.; Schuchardt, M.; Tölle, M.; Wenning, V.; Schaeffner, E.S.: Prevalence of reduced kidney function and albuminuria in older adults: the Berlin Initiative Study, Nephrol Dial Transplant., 2016.

4.   Reshetnik, A.; Gohlisch, C.; Zidek, W.; Tölle, M.; van der Giet, M.: Central blood pressure assessment using oscillometry is feasible for everyday clinical practice, J Hum Hypertens.; 2016.

5.   Reshetnik, A.; Gohlisc,h C.; Zidek, W.; Tölle, M.; van der Gie,t M.: Validation of the Tel-O-GRAPH, a new oscillometric blood pressure-measuring device, according to the British Hypertension Society protocol, Blood Press Monit., 2016.

6.   Tölle, M.; Klöckl, L.; Wiedon, A,; Zidek, W.; van der Giet, M.; Schuchardt, M: Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3, Biochem Biophys Res Commun., 2016.

7.    Annema W.; Willemsen, H.M.; de Boer, J.F.; Dikkers, A.; van der Giet, M.; Nieuwland, W.; Muller Kobold, A.C.; van Pelt, L.J.; Slart, R.H.; van der Horst, I.C.; Dullaart, R.P.; Tio, R.A.; Tietge, U.J.: HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels, J Clin Lipidol, 2016.

8.   Michalick, L.; Erfinanda, L.; Weichelt, U.; van der Giet, M.; Liedtke, W.; Kuebler, W.M.: Transient Receptor Potential Vanilloid 4 and Serum Glucocorticoid-regulated Kinase 1 Are Critical Mediators of Lung Injury in Overventilated Mice In Vivo, Anesthesiology, 2016.

9.  de Fijter, J.W.; Holdaas, H.; Øyen, O.; Sanders, J.S.; Sundar, S.; Bemelman, F.J.; Sommerer, C.; Pascual, J.; Avihingsanon, Y.; Pongskul, C.; Oppenheimer, F.; Toselli, L.; Russ, G.; Wang, Z.; Lopez, P.; Kochuparampil, J.; Cruzado, J.M.; van der Giet, M.; ELEVATE Study Group: Early conversion from calcineurin inhibitor- to everolimus-based therapy following kidney transplantation: Results of the randomized ELEVATE trial, Am J Transplant, 2016.

10.  Ott, C.; Lobo, M.D.; Sobotka, P.A.; Mahfoud, F.; Stanton, A.; Cockcroft, J.; Sulke, N.; Dolan, E.; van der Giet, M.; Hoyer, J.; Furniss, S.S.; Foran, J.P.; Witkowski, A.; Januszewicz, A.; Schoors, D.; Tsioufis, K.; Rensing, B.J.; Saxena, M.; Scott, B.; Ng, G.A.; Achenbach, S.; Schmieder, R.E.: Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension, J Am Heart Assoc, 2016.

Publikationen 2015

1.     Prüfer, N.; Kleuser, B.; van der Giet, M.: The role of serum amyloid A and sphingosine-1-phosphate on HDL functionality, Biol. Chem., 2015.

2.    Schuchardt, M., Tölle, M.; van der Giet, M.: High-Density Lipoprotein: Structural and Functional Changes under Uremic Conditions and the Therapeutic Consequences, Handbook of Experimental Pharmacology, 2015. 

3.     Lobo, M.; Sobotka, P.; Stanton, A.; Cockcroft, J.; Sulke, N.; Dolan, E.; van der Giet, M.; Hoyer, J.; Furniss , S.; Foran, J.; Witkowski, A.; Januszewicz, A.; Schoors, D.; Tsioufis, K.; Rensing, B.; Scott, B.; Ng, A.; Ott, C.;  Schmieder, R.: Central arteriovenous anastomosis for patients with uncontrolled hypertension (the ROX CONTROL HTN Study): a randomised controlled trial, Lancet.

4.    Van der Giet, M.; Henkel, C.; Schuchardt, M.; Tölle, M.: Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects, Curr Pharm Des., 2015.

5.     Yu ,S.; Xu, X.; Yigit, C.; van der Giet, M.; Zidek, W.; Jankowski, J.; Dzubiella, J.; Ballauff, M.: Interaction of human serum albumin with short polyelectrolytes: a study by calorimetry and computer simulations, Soft Matter, 2015.

6.     van der Giet, M.; Tölle, M.: New Hypertension Guidelines: Progression or a Step Backwards in Hypertension?, Curr Hypertens Rep., 2015.

7.      Tölle, M.; Reshetnik, A.; Schuchardt, M.; Höhne, M.; van der Giet, M: Arteriosclerosis and vascular calcification: causes, clinical assessment and therapy, Eur J Clin Invest., 2015.

8.      Ebert, N.; Loesment, A.; Martus, P.; Jakob, O.; Gaedeke, J.; Kuhlmann, M.; Bartel, J.; Schuchardt, M.; Tölle, M.; Huang, T.; van der Giet, M.; Schaeffner, E.: Iohexol plasma clearance measurement in older adults with chronic kidney disease-sampling time matters, Nephrol Dial Transplant, 2015.

9.      van der Giet, M.: [Diabetic nephropathy: Antihypertensives don't reduce mortality] (Article in German), Dtsch Med Wochenschr., 2015.

10.    Reshetnik, A. Scheurig-Muenkler, C.; van der Giet, M.;  Tölle, M.: High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease, Clin Case Rep. 2015.

Publikationen 2012

1.     Schaeffner, E.S., et al., Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med, 2012, 157(7):471-81.

2.     Schuchardt, M.; Tölle, M.; van der Giet, M.: P2Y purinoceptors as potential emerging therapeutical target in vascular disease. Curr Pharm Des., 2012.

3.    Weiss, W.; Gohlisch, C.; Harsch-Gladisch, C.; Tölle, M.; Zidek, W.; van der Giet, M.: Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device. Blood Press Monit., 2012, 17(3):128-31. 

4.    Seibert, F.S.; van der Giet, M.; Zidek, W.; Westhoff, T.H.: Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome revisited. Clin Nephrol., 2012 77(4): p. 345-6.

5.    Danquah, I.; Bedu-Addo, G.; Terpe, K.J.; Micah, F.; Amoako, Y. A.; Awuku, Y.A.; Dietz, E.; van der Giet, M.; Spranger, J.; Mockenhaupt, F.P.: Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health, 2012. 12: p. 210.

6.    Tölle, M.; Huang, T.; Schuchardt, M.; Jankowski, V.; Prüfer, N.; Jankowski, J.; Tietge, U.J.; Zidek, W.; van der Giet, M.: High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. 2012. Cardiovasc Res. 94(1):154-62.

7.    Weichhart, T.; Kopecky, C.; Kubicek, M.; Haidinger, M.; Döller, D.; Katholnig, K., Suarna, C.; Eller, P.; Tölle, M.; Gerner, C.; Zlabinger, G.J.; van der Giet, M.; Hörl, W.H.; Stocker, R.; Säemann, M.D.: Serum amyloid A in uremic HDL promotes inflammation. 2012. J Am Soc Nephrol. 23(5):934-47.

8.    Wiedon, A.; Tölle, M.; Bastine, J.; Schuchardt, M.; Huang, T.; Jankowski, V.; Jankowski, J.; Zidek, W.; van der Giet, M.: Uridine adenosine tetraphosphate (Up4A) is a strong inductor of smooth muscle cell migration via activation of the P2Y2 receptor and cross-communication to the PDGF receptor. Biochem Biophys Res Commun. 2012. 417(3):1035-40.

9.    de Boer, J.F.; Annema, W.; Schreurs, M.; van der Veen, J.N.; van der Giet, M.; Nijstad, N.; Kuipers, F.; Tietge, U.J.: Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice. J Lipid Res. 2012. 53(3):348-57.

10.    Schuchardt, M.; Tölle, M.; Prüfer, J.; Prüfer, N.; Huang, T.; Jankowski, V.; Jankowski, J.; Zidek, W.; van der Giet, M.: Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification. Kidney Int. 2012. 81(3):256-65.

11.     van der Giet, M., [Dual blockade of the renin-angiotensin system in hypertensive treatment: no]. Dtsch Med Wochenschr, 2012. 137(48): p. 2499.

12.    Pagonas, N.; Hörstrup, J.; Schmidt, D.; Benz, P.; Schindler, R.; Reinke, P.; van der Giet, M.; Zidek, W; Westhoff, T.H.: Prophylaxis of recurrent urinary tract infection after renal transplantation by cranberry juice and L-methionine. 2012. Transplant Proc. 2012. 44(10):3017-21.

Publikationen 2011

1. Zeier, M.; Van Der Giet, M.: Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation? Transpl Int, 2011. 24(1): p. 30-42.

2.     Seibert, F.; Behrendt, C.; Schmidt, S.; van der Giet, M.; Zidek, W.; Westhoff, T.H.: Differential effects of cyclosporine and tacrolimus on arterial function. Transpl Int. 2011. 24(7):708-15.

3.     Schuchardt, M.; Tölle, M.; Prüfer, J.; van der Giet, M.: Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. Br J Pharmacol. 2011. 163(6):1140-62.

4.    http://www.ncbi.nlm.nih.gov/pubmed/20972769 Van Linthout, S.; Spillmann, F.; Graiani, G.; Miteva, K.; Peng, J.; Van Craeyveld, E.; Meloni, M.; Tölle, M.; Escher, F.; Subasigüller, A.; Doehner, W.; Quaini, F.; De Geest, B.; Schultheiss, H.P.; Tschöpe, C.: Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation. J Mol Med (Berl). 2011. 89(2):151-60.

5.    Jankowski, V.; Tölle, M.; Santos, R.A.; Günthner, T.; Krause, E.; Beyermann, M.; Welker, P.; Bader, M.; Pinheiro, S.V.; Sampaio, W.O.; Lautner, R.; Kretschmer, A.; van der Giet, M.; Zidek, W.; Jankowski, J.: Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects. FASEB J. 2011. 25(9):2987-95.

6.    Schuchardt, M.; Prüfer, J.; Prüfer, N.; Wiedon, A.; Huang, T.; Chebli, M.; Jankowski, V.; Jankowski, J.; Schäfer-Korting, M.; Zidek, W.; van der Giet, M.; Tölle, M.: The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation. J Mol Med (Berl). 2011. 89(8):799-810.

Publikationen 2010

1. Annema, W.; Nijstad, N.; Tölle, M.; de Boer, J.F.; Buijs, R.V.; Heeringa, P.; van der Giet, M.; Tietge, U.J.: Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2). J Lipid Res. 2010. 51(4):743-54.

2. Arndt, R.; Schmidt, S.; Loddenkemper, C.; Grünbaum, M.; Zidek, W.; van der Giet, M., Westhoff, T.H.: Noninvasive evaluation of renal allograft fibrosis by transient elastography--a pilot study. Transpl Int. 2010. 23(9):871-7.

3. Bode, C.; Sensken, S.C.; Peest, U.; Beutel, G.; Thol, F.; Levkau, B.; Li, Z.; Bittman, R.; Huang, T.; Tölle, M.; van der Giet, M.; Gräler, M.H.: Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. J Cell Biochem. 2010. 109(6):1232-43.

4. Hoffmann, C.; Compton, F.; Schäfer, J.H.; Steiner, U.; Fuller, T.F.; Schostak, M.; Zidek, W.; van der Giet, M.; Westhoff, T.H.: Intraoperative assessment of kidney allograft perfusion by laser-assisted indocyanine green fluorescence videography. Transplant Proc. 2010. 42(5):1526-30.

5. Potteck, H.; Nieuwenhuis, B.; Lüth, A.; van der Giet, M.; Kleuser, B.: Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation. 2010. 26(1):67-78.

6. Schaeffner, E.S., van der Giet, M.; Gaedeke, J.; Tölle, M.; Ebert, N.; Kuhlmann, M.K.; Martus, P.: The Berlin initiative study: the methodology of exploring kidney function in the elderly by combining a longitudinal and cross-sectional approach. Eur J Epidemiol., 2010. 25(3):203-10.

7. Tolle, M., Schuchardt, M.; van der Giet, M.: Relevance of sphingolipids in the pleiotropic protective effects of high-density lipoproteins. Curr Pharm Des, 2010. 16(13): p. 1468-79.

8. Tölle, M.; Schuchardt, M.; Wiedon, A.; Huang, T.; Klöckel, L.; Jankowski, J.; Jankowski, V.; Zidek, W.; van der Giet, M.: Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol. 2010. 161(3):530-40.

9. van der Giet, M.; Tölle, M.; Pratico, D.; Lufft, V.; Schuchardt, M.; Hörl, M.P.; Zidek, W.; Tietge, U.J.: Increased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease. J Mol Med (Berl)., 2010. 88(1):75-83.

10. Wassertheurer, S.; Kropf, J.; Weber, T.; van der Giet, M.; Baulmann, J.; Ammer, M.; Hametner, B.; Mayer, C.C.; Eber, B.; Magometschnigg, D.: A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hypertens., 2010. 24(8):498-504.

11. Wei, W.; Tölle, M.; Zidek, W.; van der Giet, M.: Validation of the mobil-O-Graph: 24 h-blood pressure measurement device. Blood Press Monit., 2010. Aug;15(4):225-8.

Publikationen 2009

1.  Günthner, T.; Jankowski, V.; Kretschmer, A.; Nierhaus, M.; van der Giet, M.; Zidek, W.; Jankowski, J.: Endothelium and vascular smooth muscle cells in the context of uremia. Semin Dial., 2009. 22(4):428-32.

2. Jankowski, V.; van der Giet, M.; Mischak, H.; Morgan, M.; Zidek, W.; Jankowski, J.: Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system. Br J Pharmacol., 2009. 157(7):1142-53.

3. Nijstad, N.; Wiersma, H.; Gautier, T.; van der Giet, M., Maugeais, C.; Tietge, U.J.: Scavenger receptor BI-mediated selective uptake is required for the remodeling of high density lipoprotein by endothelial lipase. J Biol Chem. 2009. 284(10):6093-100.

4.  Schmidt, S.; Foert, E.; Zidek, W.; van der Giet, M.; Westhoff, T.H.: Emphysematous pyelonephritis in a kidney allograft. Am J Kidney Dis. 2009. 53(5):895-7.

5. Westermann, D.; Riad, A.; Richter, U.; Jäger, S.; Savvatis, K.; Schuchardt, M.; Bergmann, N.; Tölle, M.; Nagorsen, D.; Gotthardt, M.; Schultheiss, H.P.; Tschöpe, C.: Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure. Basic Res Cardiol. 2009. 104(5):499-509.

6. Westhoff, T.H.; Schmidt, S.; Meissner, R.; Zidek, W.; van der Giet, M.: The impact of pulse pressure on the accuracy of wrist blood pressure measurement. J Hum Hypertens. 2009. 23(6):391-5.

7.  Westhoff, T.H.; Vergoulidou, M.; Loddenkemper, C.; Schwartz, S.; Hofmann, J.; Schneider, T.; Zidek, W.; van der Giet, M.: Chronic norovirus infection in renal transplant recipients. Nephrol Dial Transplant. 2009. 24(3):1051-3.

Publikationen 2008

1. Nissel, R.; Faraj, S.; Sommer, K.; Henning, L.; van der Giet, M.; Querfeld, U.: Oxidative stress markers in young hemodialysis patients - a pilot study. Clin Nephrol., 2008. 70(2):135-43.

2. Schmidt, S.; Westhoff, T.H.; Krauser, P.; Zidek, W.; van der Giet, M.: The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells. Nephrol Dial Transplant., 2008. 23(1):65-71.

3. Schmidt S, Westhoff TH, Krauser P, Ignatius R, Jankowski J, Jankowski V, Zidek W, van der Giet M.: The uraemic toxin phenylacetic acid impairs macrophage function. Nephrol Dial Transplant., 2008. 23 (11): p. 3485-93.

4.  Tölle M.; Jankowski, V.; Schuchardt, M.; Wiedon, A.; Huang, T.; Hub, F.; Kowalska, J.; Jemielity, J.; Guranowski, A.; Loddenkemper, C.; Zidek, W.; Jankowski, J.; van der Giet, M.: Adenosine 5'-tetraphosphate is a highly potent purinergic endothelium-derived vasoconstrictor. Circ Res., 2008. 103(10):1100-8.

5.  Tölle, M.; Pawlak, A.; Schuchardt, M.; Kawamura, A.; Tietge, U.J.; Lorkowski, S.; Keul, P.; Assmann, G.; Chun, J.; Levkau, B.; van der Giet, M.; Nofer, J.R.: HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol., 2008. 28(8):1542-8.

6. Tölle, M.; van der Giet, M.: Cardiorenovascular effects of urotensin II and the relevance of the UT receptor. Peptides, 2008. 29(5): p. 743-63.

7. van der Giet, M.; Tölle, M.; Kleuser, B.: Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease. Biol Chem., 2008. 389(11): p. 1381-90.

8. Westhoff, T.H.; Schmidt, S.; Gross, V.; Joppke, M.; Zidek, W.; van der Giet, M.; Dimeo, F.: The cardiovascular effects of upper-limb aerobic exercise in hypertensive patients. J Hypertens. 2008. 26(7):1336-42.

9. Westhoff, T.H.; Schmidt, S.; Zidek, W.; van der Giet, M.: Validation of the Stabil-O-Graph blood pressure self-measurement device. J Hum Hypertens., 2008. 22(3):233-5.

Publikationen 2007

1.       Jankowski, V.; Karadogan, S.; Vanholder, R.; Nofer, J.R.; Herget-Rosenthal, S.; van der Giet, M.; Tölle, M.; Tran, T.N.; Zidek, W.; Jankowski, J.: Paracrine stimulation of vascular smooth muscle proliferation by diadenosine polyphosphates released from proximal tubule epithelial cells. Kidney Int, 2007. 71(10): p. 994-1000.

2.      Jankowski, V.; Meyer, A.A.; Schlattmann, P.; Gui, Y.; Zheng, X.L.; Stamcou, I.; Radtke, K.; Tran, T.N.; van der Giet, M.; Tölle, M.; Zidek, W., Jankowski, J.: Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives. Arterioscler Thromb Vasc Biol, 2007. 27(8): p. 1776-81.

3. Jankowski, V.; Vanholder, R.; van der Giet, M.; Tölle, M.; Karadogan, S.; Gobom, J., Furkert, J.; Oksche, A.; Krause, E.; Tran, T.N.; Tepel, M., Schuchardt, M., Schlüter, H.; Wiedon, A.; Beyermann, M.; Bader, M.; Todiras, M.; Zidek, W.; Jankowski, J.: Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol, 2007. 27(2): p. 297-302.

4.      Keller, C.D.; Rivera Gil, P.; Tölle, M.; van der Giet, M.; Chun, J.; Radeke, H.H.; Schäfer-Korting, M.; Kleuser, B.: Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. Am J Pathol, 2007. 170(1): p. 281-92.

5.      Keul, P.; Tölle, M.; Lucke, S.; von Wnuck Lipinski, K.; Heusch, G.; Schuchardt, M.; van der Giet, M.; Levkau, B.: The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol, 2007. 27(3): p. 607-13.

6.      Schmidt, S.; Westhoff, T.H.; Compton, F.; Zidek, W.; van der Giet, M.:Avoiding the cross-talk phenomenon when assessing cardiac output using the transpulmonary thermodilution technique via the femoral vein access. Crit Care Med, 2007. 35(11): p. 2670.

7.       Schmidt, S.; Westhoff, T.H.; Hofmann, C.; Schaefer, J.H.; Zidek, W.; Compton, F.; van der Giet, M.:Effect of the venous catheter site on transpulmonary thermodilution measurement variables. Crit Care Med, 2007. 35(3): p. 783-6.

8.       Tölle, M.; Levkau, B.; Kleuser, B.; van der Giet, M.: Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds. Eur J Clin Invest, 2007. 37(3): p. 171-9.

9.       Westhoff, T.H.; Franke, N.; Schmidt, S.; Vallbracht-Israng, K.; Meissner, R.; Yildirim, H.; Schlattmann, P.; Zidek, W.; Dimeo, F.; van der Giet, M.: Too old to benefit from sports? The cardiovascular effects of exercise training in elderly subjects treated for isolated systolic hypertension. Kidney Blood Press Res, 2007. 30(4): p. 240-7.

10.      Westhoff, T.H.; Franke, N.; Schmidt, S.; Vallbracht-Israng, K.; Zidek, W.; Dimeo, F.; van der Giet, M.: Beta-blockers do not impair the cardiovascular benefits of endurance training in hypertensives. J Hum Hypertens, 2007. 21(6): p. 486-93.

11.      Westhoff, T.H.; Schmidt, S.; Glander, P.; Liefeld, L.; Martini, S.; Offermann, G.; Neumayer, H.H.; Zidek, W.; van der Giet, M.; Budde, K.: The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients. Nephrol Dial Transplant, 2007. 22(8): p. 2354-8.

12.      Westhoff, T.H.; Schmidt, S.; Vallbracht-Israng, K.; Yildirim, H.; Franke, N.; Dimeo, F.; Zidek, W.; van der Giet, M.:Small artery elasticity assessed by pulse wave analysis is no measure of endothelial dysfunction. J Hypertens, 2007. 25(3): p. 571-6.

13.      Westhoff, T.H. and M. van der Giet: Tacrolimus in the treatment of idiopathic nephrotic syndrome. Expert Opin Investig Drugs, 2007. 16(7): p. 1099-110.

Publikationen 2006

1.      Becker, S.; Schomburg, L.; Renko, K.; Tölle, M.; van der Giet, M.; Tietge, U.J.: Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans. Biochem Biophys Res Commun, 2006. 339(3): p. 833-9.

2.      Tölle, M.; Giebing, G.; Tietge, U.J.; Jankowski, J.; Jankowski, V.; Henning, L.; Hörl, M.P.; Weiss, W.; Zidek, W.; van der Giet, M.: Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation. J Hypertens, 2006. 24(10): p. 1991-2000.

3.      van der Giet, M. and W. Zidek, [Haemodialysis and hypertension]. Dtsch Med Wochenschr, 2006. 131(46): p. 2605-9.

4.      Westhoff, T.H.; Loddenkemper, C.; Hörl, M.P.; Schmidt, S.; Anagnostopoulos, I.; Hummel, M.; Zidek, W.; van der Giet, M.: Dermatopathic lymphadenopathy: a differential diagnosis of enlarged lymph nodes in uremic pruritus. Clin Nephrol, 2006. 66(6): p. 472-5.

5.      Westhoff, T.H.; Schmidt, S.; Zidek, W.; Beige, J.; van der Giet, M.: Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome. Clin Nephrol, 2006. 65(6): p. 393-400.

6.      Westhoff, T.H.; Straub-Hohenbleicher, H.; Basdorf, M.; van der Giet, S.; Schmidt, S.; Offermann, G.; Schlattmann, P.; Zidek, W.; van der Giet, M.: Time-dependent effects of cadaveric renal transplantation on arterial compliance in patients with end-stage renal disease. Transplantation, 2006. 81(10): p. 1410-4.

7.      Westhoff, T.H.; Waldherr, R.; Loddenkemper, C.; Ries, W.; Zidek, W.; van der Giet, M.: Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease? Clin Nephrol, 2006. 65(3): p. 203-7.

8.      Westhoff, T.H.; Zidek, W., Uharek, L.; Steinhoff-Georgieva, J.; van der Giet, M.: Impairment of renal function in Schnitzler's syndrome. J Nephrol, 2006. 19(5): p. 660-3.

Publikationen 2005

1.      Giebing, G.; Tölle, M.; Jürgensen, J.; Eichhorst, J.; Furkert, J.; Beyermann, M.; Neuschäfer-Rube, F.; Rosenthal, W.; Zidek, W.; van der Giet, M.; Oksche, A.: Arrestin-independent internalization and recycling of the urotensin receptor contribute to long-lasting urotensin II-mediated vasoconstriction. Circ Res, 2005. 97(7): p. 707-15.

2.      Jankowski, V.; Tölle, M.; Vanholder, R.; Schönfelder, G.; van der Giet, M.; Henning, L.; Schlüter, H.; Paul, M.; Zidek, W.; Jankowski, J.: Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nat Med, 2005. 11(2): p. 223-7.

3.      Jankowski, V.; Vanholder, R.; van der Giet, M.; Henning, L.; Tölle, M.; Schönfelder, G.; Krakow, A.; Karadogan, S.; Gustavsson, N.; Gobom, J.; Webb,  J.; Lehrach, H.; Giebing, G.; Schlüter, H.; Hilgers, K.F.; Zidek, W.; Jankowski, J.: Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysis. Hypertension, 2005. 46(3): p. 591-7.

4.      Tölle, M.; Levkau, B.; Keul, P.; Brinkmann, V.; Giebing, G.; Schönfelder, G.; Schäfers, M.; von Wnuck Lipinski, K.; Jankowski, J.; Jankowski, V.; Chun, J.; Zidek, W.; Van der Giet, M.: Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ Res, 2005. 96(8): p. 913-20.

5.      van der Giet, M., [Isolated systolic hypertension]. Dtsch Med Wochenschr, 2005. 130(46): p. 2653-6.

6.      van der Giet, M. and M. Paul, [New tendencies in combination antihypertensive therapy]. MMW Fortschr Med, 2005. 147(46): p. 44-6.

7.      Westhoff, T.H.; Scheid, S.; Tölle, M.; Kaynak, B.; Schmidt, S.; Zidek, W.; Sperling, S.; van der Giet, M.: A physiogenomic approach to study the regulation of blood pressure. Physiol Genomics, 2005. 23(1): p. 46-53.

8.      Westhoff, T.H.; Straub-Hohenbleicher, H.; Schmidt, S.; Tölle, M.; Zidek, W.; van der Giet, M.: Convenience of ambulatory blood pressure monitoring: comparison of different devices. Blood Press Monit, 2005. 10(5): p. 239-42.

9.      Zhu, Z.; Zhu, S.; Liu, D.; Yu, Z.; Yang, Y.; van der Giet, M.; Tepel, M.: GATA4-mediated cardiac hypertrophy induced by d-myo-inositol 1,4,5-tris-phosphate. Biochem Biophys Res Commun, 2005. 338(2): p. 1236-40.

Publikationen 2003

1.     Jankowski, J.; Jankowski, V.; Laufer, U.; van der Giet, M.; Henning, L.; Tepel, M.; Zidek, W.; Schlüter, H.: Identification and quantification of diadenosine polyphosphate concentrations in human plasma. Arterioscler Thromb Vasc Biol, 2003. 23(7): p. 1231-8.

2.     Jankowski, J.; Schlüter, H.; Henning, L.; van der Giet, M.; Jankowski, V.; Zidek, W.; Tepel M.: The AN69 hemofiltration membrane has a decreasing effect on the intracellular diadenosine pentaphosphate concentration of platelets. Kidney Blood Press Res, 2003. 26(1): p. 50-4.

3.     Jankowski, J.; van der Giet, M.; Jankowski, V.; Schmidt, S.; Hemeier, M.; Mahn, B.; Giebing, G.; Tolle, M.; Luftmann, H.; Schluter, H.; Zidek, W.; Tepel, M.: Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest, 2003. 112(2): p. 256-64.

4.     Tepel, M.; van der Giet, M.; Statz, M.; Jankowski, J.; Zidek, W.: The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial.Circulation, 2003. 107(7): p. 992-5.

5.     van der Giet, M.; Zidek, W.: [Isolated systolic hypertension. Need for new assessment]. MMW Fortschr Med, 2003. 145(7): p. 53-4.

6.     Westhoff, T.; Jankowski, J.; Schmidt, S.; Luo, J.; Giebing, G.; Schlüter, H.; Tepel, M.; Zidek, W.; van der Giet, M.: Identification and characterization of adenosine 5'-tetraphosphate in human myocardial tissue. J Biol Chem, 2003. 278(20): p. 17735-40.

Publikationen 2001

Publikationen 1999

1.      Jankowski, J.; Potthoff, W.; van der Giet, M.; Tepel, M.; Zidek, W.; Schlüter, H.: High-performance liquid chromatographic assay of the diadenosine polyphosphates in human platelets. Anal Biochem, 1999. 269(1): p. 72-8.

2.     Jankowski, J.; Tepel, M.; van der Giet, M.; Tente, I.M.; Henning, L.; Junker, R.; Zidek, W.; Schlüter, H.: Identification and characterization of P(1), P(7)-Di(adenosine-5')-heptaphosphate from human platelets. J Biol Chem, 1999. 274(34): p. 23926-31.

3.     Luo, J.; Jankowski, J.; Knobloch, M.; van der Giet, M.; Gardanis, K.; Russ, T.; Vahlensieck, U.; Neumann,  J.; Schmitz, W; Tepel, M.; Deng, M.C.; Zidek, W.; Schlüter, H.: Identification and characterization of diadenosine 5',5"'-P1,P2 -diphosphate and diadenosine 5',5"'-P1,P3-triphosphate in human myocardial tissue. FASEB J, 1999. 13(6): p. 695-705.

4.     Tepel, M.; Pytlik, M.; van der Giet, M.; Schlüter, H.; Jankowski, J.; Zidek, W.: Effect of dexamethasone on the lymphocytic Na+/H+ antiporter activity. J Hypertens, 1999. 17(11): p. 1553-6.

5.     Tepel, M.; van der Giet, M.; Brukamp, K.; Weyer, J.; Zidek, W.: Regulation of the Na+/H+ antiporter in patients with mild chronic renal failure: effect of glucose. Kidney Int, 1999. 56(1): p. 172-80.

6.     Tepel, M.; van der Giet, M.; Zidek, W.: Therapy of hypertensive emergencies. Saudi J Kidney Dis Transpl, 1999. 10(3): p. 279-82.

7.      van der Giet, M.; Cinkilic, O.; Jankowski, J.; Tepel, M.; Zidek, W.; Schlüter, H.: Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney. Br J Pharmacol, 1999. 127(6): p. 1463-9.

AG Compton